Retrospective Study to Capture Dosing and Treatment Outcome Data in Subjects With Severe Congenital Protein C Deficiency Who Were Treated With Protein C Concentrate Under an Emergency Use IND

Status:	Completed
Conditions:	Hospital, Metabolic
Therapuetic Areas:	Pharmacology / Toxicology, Other
Healthy:	No
Age Range:	Any
Updated:	10/25/2017
Start Date:	June 2005
End Date:	December 2005

A Retrospective Study to Capture Dosing and Treatment Outcome Data in Subjects With Severe Congenital Protein C Deficiency Who Were Treated With Protein C Concentrate Under an Emergency Use IND

This is a data collection study with the purpose of capturing dosing and treatment outcome
data in subjects with severe congenital protein C deficiency who were treated with protein C
concentrate under an Emergency Use Investigational New Drug Application (IND).

Inclusion Criteria:

- Subject treated with protein C concentrate under a Baxter Healthcare Corporation
Emergency Use IND

- Subject with diagnosis of severe congenital protein C deficiency

- Subject or parent/legally authorized representative has provided written informed
consent

We found this trial at

sites

University of Texas Medical Branch

301 University Blvd
Galveston, Texas 77555

(409) 772-1011